Similarly, a propensity score matched study including 13,129 patients and 35,020 procedures showed that the perioperative use of GLP-1 RA in patients with diabetes was associated with a significant reductions in risk-adjusted readmission, wound dehiscence, and occurrence of hematoma [24]. Here, GLP1R is linked to diabetes mellitus.